1. Home
  2. AGIO vs BLBD Comparison

AGIO vs BLBD Comparison

Compare AGIO & BLBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AGIO
  • BLBD
  • Stock Information
  • Founded
  • AGIO 2007
  • BLBD 1927
  • Country
  • AGIO United States
  • BLBD United States
  • Employees
  • AGIO N/A
  • BLBD N/A
  • Industry
  • AGIO Biotechnology: Pharmaceutical Preparations
  • BLBD Construction/Ag Equipment/Trucks
  • Sector
  • AGIO Health Care
  • BLBD Consumer Discretionary
  • Exchange
  • AGIO Nasdaq
  • BLBD Nasdaq
  • Market Cap
  • AGIO 1.4B
  • BLBD 1.1B
  • IPO Year
  • AGIO 2013
  • BLBD N/A
  • Fundamental
  • Price
  • AGIO $27.66
  • BLBD $33.71
  • Analyst Decision
  • AGIO Buy
  • BLBD Strong Buy
  • Analyst Count
  • AGIO 8
  • BLBD 7
  • Target Price
  • AGIO $56.57
  • BLBD $58.21
  • AVG Volume (30 Days)
  • AGIO 745.1K
  • BLBD 527.0K
  • Earning Date
  • AGIO 05-01-2025
  • BLBD 05-07-2025
  • Dividend Yield
  • AGIO N/A
  • BLBD N/A
  • EPS Growth
  • AGIO N/A
  • BLBD 69.33
  • EPS
  • AGIO 11.64
  • BLBD 3.21
  • Revenue
  • AGIO $36,498,000.00
  • BLBD $1,343,366,000.00
  • Revenue This Year
  • AGIO $41.13
  • BLBD $8.82
  • Revenue Next Year
  • AGIO $234.96
  • BLBD $7.91
  • P/E Ratio
  • AGIO $2.38
  • BLBD $10.50
  • Revenue Growth
  • AGIO 36.07
  • BLBD 10.59
  • 52 Week Low
  • AGIO $23.42
  • BLBD $30.04
  • 52 Week High
  • AGIO $62.58
  • BLBD $59.40
  • Technical
  • Relative Strength Index (RSI)
  • AGIO 44.94
  • BLBD 49.45
  • Support Level
  • AGIO $26.87
  • BLBD $32.61
  • Resistance Level
  • AGIO $28.24
  • BLBD $35.43
  • Average True Range (ATR)
  • AGIO 1.94
  • BLBD 2.08
  • MACD
  • AGIO 0.22
  • BLBD 0.18
  • Stochastic Oscillator
  • AGIO 66.15
  • BLBD 68.09

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

Share on Social Networks: